Literature DB >> 14648949

The aetiology and outcome of 170 ulnar nerve lesions confirmed with electrophysiological testing.

Ian J Harding1, Ian M Morris.   

Abstract

The authors have studied 148 consecutive patients with 170 electrophysiologically confirmed ulnar nerve lesions, who were followed up for one to six years (median 3.8 years) to determine clinical progress and outcome. Injury and intra-operative pressure accounted for 12.9% and 7.1% of lesions respectively; 58.2% were idiopathic with no identified clinical aetiological factor. Eighty-three percent received non-operative treatment initially; 21% of these required operative intervention following further clinical/electrophysiological assessment. Partial or complete recovery occurred in 92% of intra-operative, 64% of idiopathic and 50% of injury cases respectively. Ulnar nerve lesions predominate in males and can be treated non-operatively providing clinical and electrophysiological monitoring is possible. Bilaterality is common and should be excluded. Lesions due to injury have a worse prognosis than those caused by direct continuous or repeated pressure, inflammation or where no aetiological factor exists.

Entities:  

Mesh:

Year:  2003        PMID: 14648949

Source DB:  PubMed          Journal:  Acta Orthop Belg        ISSN: 0001-6462            Impact factor:   0.500


  3 in total

1.  Shear-wave elastography: a new potential method to diagnose ulnar neuropathy at the elbow.

Authors:  Łukasz Paluch; Bartłomiej Noszczyk; Żaneta Nitek; Jerzy Walecki; Katarzyna Osiak; Piotr Pietruski
Journal:  Eur Radiol       Date:  2018-06-01       Impact factor: 5.315

2.  Diagnostic value of ultrasonography versus electrodiagnosis in ulnar neuropathy.

Authors:  Seyed Mansoor Rayegani; Seyed Ahmad Raeissadat; Elham Kargozar; Shahram Rahimi-Dehgolan; Elham Loni
Journal:  Med Devices (Auckl)       Date:  2019-02-22

3.  Ultrasound: A Useful Tool in the Diagnosis and Localization of Ulnar Neuropathy at the Elbow.

Authors:  Amanda Honsvall Hoefler; Emily M Miller; Yuka Kobayashi; Andrew W Gottschalk
Journal:  Ochsner J       Date:  2021
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.